Literature DB >> 15678315

Unexpected recovery from prolonged hypoglycemic coma: a protective role of metformin?

Jean-Daniel Lalau, Kamel Masmoudi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15678315     DOI： 10.1007/s00134-004-2540-x

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

Review 1.  Energy metabolism in critically ill patients: lactate is a major oxidizable substrate.

Authors:  X M Leverve
Journal:  Curr Opin Clin Nutr Metab Care       Date:  1999-03       Impact factor: 4.294

Review 2.  Metformin and lactic acidosis in diabetic humans.

Authors:  J D Lalau; J M Race
Journal:  Diabetes Obes Metab       Date:  2000-06       Impact factor: 6.577

Review 3.  Metformin: intrinsic vasculoprotective properties.

Authors:  N F Wiernsperger
Journal:  Diabetes Technol Ther       Date:  2000       Impact factor: 6.118

Review 4.  Effects of hypothermia on energy metabolism in Mammalian central nervous system.

Authors:  Maria Erecinska; Marianne Thoresen; Ian A Silver
Journal:  J Cereb Blood Flow Metab       Date:  2003-05       Impact factor: 6.200

5.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321
  5 in total
  3 in total

Review 1.  Lactic acidosis induced by metformin: incidence, management and prevention.

Authors:  Jean-Daniel Lalau
Journal:  Drug Saf       Date:  2010-09-01       Impact factor: 5.606

Review 2.  Therapeutic Concentrations of Metformin: A Systematic Review.

Authors:  Farshad Kajbaf; Marc E De Broe; Jean-Daniel Lalau
Journal:  Clin Pharmacokinet       Date:  2016-04       Impact factor: 6.447

3.  The prognostic value of blood pH and lactate and metformin concentrations in severe metformin-associated lactic acidosis.

Authors:  Farshad Kajbaf; Jean-Daniel Lalau
Journal:  BMC Pharmacol Toxicol       Date:  2013-04-12       Impact factor: 2.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.